01 How it works
GHK-Cu delivers copper to tissues and switches on genes involved in repair. It stimulates collagen and elastin production, supports wound healing and has antioxidant effects. Natural levels fall sharply between your twenties and sixties.
02 Common uses
03 Run profile
Started low and stepped up over about two months, then held. Once a day, in twelve-week blocks with a four-week break.
The profile shows the shape. Ask for the numbers for your vial, your goal and your timeline.
04 Pairs well with
05 What to watch for
It stings more than most peptides — injection-site irritation, redness and swelling are expected. Mixing with more water (a less concentrated solution), rotating sites and brief icing help. Anyone with Wilson’s disease or another copper disorder should not use it without a doctor.
06 Evidence & status
Not approved (injectable)Strong lab evidence and decades of topical cosmetic use; injectable human data is limited.
Widely used in topical cosmetics; not FDA-approved as an injectable.
Sources
- GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin RegenerationBioMed Research International, 2015 · Review
- Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene DataInternational Journal of Molecular Sciences, 2018 · Review
- The Regenerative Potential of GHK-Cu in Aesthetic MedicineAesthetic Surgery Journal, 2026 · Review
- 503A Categories Update for September 2023Alliance for Pharmacy Compounding (summary of the FDA 29 Sept 2023 category update), 2023 · Regulator document
- FDA Announces Removal of 12 Peptides from Category 2 and Schedules PCAC MeetingsOrrick (law firm client alert), 2026 · Regulator document
- The Prohibited ListWorld Anti-Doping Agency, 2026 · Regulator document
- HHS Draft Policy Eases Enforcement on 6 Compounded PeptidesThe American Journal of Managed Care (AJMC), 2026 · Regulator document
Status and sources last checked November 3, 2026. Something out of date? Tell us.
07 How long until it works
For skin, the human evidence is for creams, not injections: in the topical studies summarised in the reviews on this page, measurable changes in skin thickness, firmness and fine lines appeared over about twelve weeks of daily use. That is where the twelve-week block in the run profile comes from.
For injected GHK-Cu there is no human trial, so no measured timescale. People report skin and hair changes on a similar twelve-week horizon, and the 2026 review of GHK-Cu in aesthetic medicine makes the same point: the laboratory case is strong, the injectable human data are thin.
08 Injected vs topical GHK-Cu
This is the comparison that matters, because the evidence sits almost entirely on one side. Topical GHK-Cu has decades of cosmetic use and human studies behind it for skin texture, firmness and photo-damage; it works where it is applied. Injected GHK-Cu is the newer practice, taken for whole-body effects on collagen and hair, and rests on cell and animal work plus the topical record.
The practical difference is the sting. Injected GHK-Cu irritates more than most peptides, which is why the run profile builds up slowly and the page suggests diluting it further. If the goal is the face, the cream has the evidence; if the goal is hair density or general collagen support, the injectable is what people use, with the honesty that it has not been tested that way.
09 Stacking
GHK-Cu is the base of the two skin blends on this site: the GLOW Stack adds BPC-157 and TB-500, the KLOW Stack adds KPV as well. No study has tested either blend in people. Standing alone, GHK-Cu is often run alongside a recovery peptide during a repair phase.
A combined vial is outside the October 2026 HHS compounding policy, which covers single-ingredient products only, and GHK-Cu is not among the six peptides it names in any case.
10 Where it stands legally
As a cosmetic ingredient in creams and serums, GHK-Cu is legal and widely sold. As an injectable it is not approved anywhere. In September 2023 the FDA placed injectable GHK-Cu in Category 2 of its compounding categories (significant safety concerns) and the non-injectable form in Category 1; in April 2026 it removed both from their categories and said it intends to put GHK-Cu to its advisory committee before the end of February 2027. Until then its compounding status is unsettled. It is not among the six peptides in the October 2026 HHS policy.
In sport, an injected substance with no regulatory approval falls under S0 of WADA’s Prohibited List; tested athletes should treat injected GHK-Cu as banned and check with their anti-doping body.
11 FAQ
Why does it sting?
It is a known trait of GHK-Cu. More dilution helps a lot.
Injectable or topical?
Topical is common in skincare; injectable is used for a systemic effect.
How long until skin changes?
Collagen remodels slowly — think in months.
Does GHK-Cu regrow hair?
Topical GHK-Cu has small human studies for hair and is the basis of several hair products. Injected GHK-Cu has no hair study in people. If hair is the goal, the topical route has the evidence.
Why does injected GHK-Cu sting so much?
The copper complex is irritating to tissue. More water in the vial (a weaker solution), rotating sites and brief icing are the fixes people use.
Can I use GHK-Cu if I have a copper problem?
Not without a doctor. Wilson’s disease and other copper disorders are the clear exclusion, because the peptide delivers copper.
Is GHK-Cu legal to compound?
Unsettled. The FDA removed it from its compounding categories in April 2026 and plans to review it formally by early 2027. It is not covered by the October 2026 HHS policy.
Educational information only — not medical advice. The Daily Stack does not sell or supply any products. Talk to a licensed healthcare professional about your own health decisions.